The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Ranked by engagement

Top topics — all time page 28

Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.

1,535 topics · page 28 of 40

TopicParticipantsRepliesViewsActivity
Coming back to: Oxidation and deamidation mass shifts, tabulated
Oxidation and deamidation mass shifts, tabulated — setting out what I have, and where I think it stops being reliable. Reading back through what has been written here about Oxidation and deamidation mass…
HFSLADAKTI+34 38 4.8k 10mo
About the Site feedback category
Bugs, friction, and the parts of the site that do not work the way you expected. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and…
JMSLVDAHKR 4 54k 10mo
Second pass at: Transit times by route, from a logged dataset
On the subject in the title: Second pass at: Transit times by route, from a logged dataset Working notes rather than a conclusion. Posting a small dataset on Transit times. It is mine, it is uncontrolled, and…
GDMGCR 2 59k 19mo
Request: export my own posts
Posting this under the heading it deserves: Request: export my own posts Everything below is what sits behind that. I have spent a fortnight trying to pin export down and I want to set out where I have got…
SCAFCV 2 57k 6mo
Cold solution and stinging: the simplest fix
Posting this under the heading it deserves: Cold solution and stinging: the simplest fix Everything below is what sits behind that. An honest uncertainty about cold solution and stinging rather than a…
ATJRCTDBTD+35 39 8.2k 30d
Clearance pathways and what renal impairment changes
Clearance pathways and what renal impairment changes Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of clearance pathways is wrong? I…
BAWADAKLS+11 15 43k 2mo
What "verified" means on our vendor pages, stated narrowly
What "verified" means on our vendor pages, stated narrowly — that is the question, and I have not found it answered plainly anywhere I have looked. A question about how a record should be read rather than…
MVFAHSCOVB+27 31 27k 7mo
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one — setting out what I have, and where I think it stops being reliable. Posting a small dataset on PIONEER 6 cardiovascular…
LCDNMNZGH+25 29 22k 1d
Fixed versus detachable needles: the trade-offs — does this still hold?
Fixed versus detachable needles: the trade-offs — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Working notes on Fixed versus detachable…
CVFHKRZSUC+8 12 39k 15h
Transit times by route, from a logged dataset
Transit times by route, from a logged dataset Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on transit times. It is mine, it is uncontrolled, and…
BESBJROFHF+34 38 3.6k 18h
Oral semaglutide bioavailability and its variability between people
Posting this under the heading it deserves: Oral semaglutide bioavailability and its variability between people Everything below is what sits behind that. I would like to know what people here actually do…
SHNKITAKAD+44 48 574 3mo
Why I ask for the gradient before I discuss the number
The question in the title: Why I ask for the gradient before I discuss the number I will give what I have already checked below so nobody repeats it. I would like to understand what this number means before I…
GPSFCNNDHK+35 39 4.9k 20mo
Coming back to: What the published dose-response for semaglutide actually looks like above 2.4 mg
The question in the title: What the published dose-response for semaglutide actually looks like above 2.4 mg I will give what I have already checked below so nobody repeats it. I would like to know what…
SCHJSATKO+23 27 9.9k 1mo
Coming back to: Telehealth prescribing models in the US
Posting this under the heading it deserves: Telehealth prescribing models in the US Everything below is what sits behind that. Telehealth prescribing models — I have the observation and I do not trust my…
LCNBHFTIEM+26 30 17k 17h
Vagal afferents and the gut-brain pathway
On the subject in the title: Vagal afferents and the gut-brain pathway Working notes rather than a conclusion. Vagal afferents — I have the observation and I do not trust my interpretation of it, so I am…
KRBSKSBCD+5 9 44k 13mo
Journal club: SELECT, absolute risk, and how it was reported
Journal club: SELECT, absolute risk, and how it was reported Writing it up because I had to work it out twice and would rather nobody else did. A question about what the numbers mean rather than what they…
MSFVJF 2 52k 1mo
Labelling requirements for research chemicals
Labelling requirements for research chemicals — setting out what I have, and where I think it stops being reliable. The question about labelling requirements for research chemicals that I actually want…
BNCGCCMLNN+5 9 45k 4mo
Severe gastroparesis and why this class is a poor fit — one year on
Severe gastroparesis and why this class is a poor fit — one year on — setting out what I have, and where I think it stops being reliable. Asking about Severe gastroparesis directly, because I have read four…
ASBRACLSB+19 23 23k 7mo
Turnaround times and what they mean for a decision — one year on
On the subject in the title: Turnaround times and what they mean for a decision — one year on Working notes rather than a conclusion. Reading back through what has been written here about Turnaround times,…
TVZVGFFEDI+25 29 22k 18mo
A parcel stationary at a customs facility for nine days — does this still hold?
The question in the title: A parcel stationary at a customs facility for nine days — does this still hold? I will give what I have already checked below so nobody repeats it. A logistics question, since the…
DBGOTKAVRJ+23 27 12k 1mo
Tirzepatide's shorter half-life and its one practical consequence
On the subject in the title: Tirzepatide's shorter half-life and its one practical consequence Working notes rather than a conclusion. Documentation question rather than a pharmacological one, but about this…
RERMNECCB+18 29 20k 8mo
Isotonicity and what happens when you get it wrong
On the subject in the title: Isotonicity and what happens when you get it wrong Working notes rather than a conclusion. I was wrong about isotonicity in a thread last spring and I would like to correct it…
ITDVILSSTK+27 31 11k 18mo
Column chemistry choices for a 40-residue peptide
Column chemistry choices for a 40-residue peptide — setting out what I have, and where I think it stops being reliable. Collecting what is known about column chemistry choices in one place, because it is…
SRDWZVGLCV+39 43 1.1k 10mo
About the Regulatory category
Research-use-only status, compounding rules, import restrictions, and the primary documents behind them. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
OBSLKEFNV 4 49k 4mo
Coming back to: Reading a supplier's product description as a marketing document
Reading a supplier's product description as a marketing document Writing it up because I had to work it out twice and would rather nobody else did. Documentation question rather than a pharmacological one,…
HBELCVHNDN+35 39 688 5mo
Follow-up: Oral contraceptives and delayed emptying: what the data shows
Oral contraceptives and delayed emptying: what the data shows — setting out what I have, and where I think it stops being reliable. A follow-up question about Oral contraceptives and delayed emptying that I…
KMPEHBMSRL+31 35 13k 18mo
Selection into a registry and what it does to the estimate
Selection into a registry and what it does to the estimate — setting out what I have, and where I think it stops being reliable. Working notes on selection rather than a conclusion. I would rather post the…
SSLMAA 2 55k 7mo
Reimbursement variation across member states
Reimbursement variation across member states Writing it up because I had to work it out twice and would rather nobody else did. Asking about reimbursement variation across member states directly, because I…
SFJSREBS+7 11 39k 3mo
Albumin binding and how it produces a long half-life
Albumin binding and how it produces a long half-life — setting out what I have, and where I think it stops being reliable. A narrow question about albumin binding, deliberately narrow, because the broad…
SDDMTBBTAM+38 44 6.6k 14mo
GLP-1 receptor distribution: central and peripheral — one year on
GLP-1 receptor distribution: central and peripheral — one year on — setting out what I have, and where I think it stops being reliable. An honest uncertainty about GLP-1 receptor distribution rather than a…
GRECSVTTTV+7 11 43k 3mo